Status:
UNKNOWN
Molecular Mechanism of Nasopharyngeal Carcinoma
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
National Health Research Institutes, Taiwan
Conditions:
Nasopharyngeal Carcinoma
Eligibility:
All Genders
30-65 years
Brief Summary
EBV, infection process, immortalization, B lymphocytes, Epithelial cells, co-culture Epstein-Barr virus (EBV) belongs to human γ-herpes viruses. Unlike other human herpes viruses, EBV can only predomi...
Detailed Description
Nasopharyngeal carcinoma (NPC), a human malignancy derived from the nasopharyngeal epithelial cells, is occurring highly frequently in Taiwan. Of note, the average ages of NPC individuals are usually ...
Eligibility Criteria
Inclusion
- diagnosis of nasopharyngeal carcinoma
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
End Date :
August 1 2005
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00155181
Start Date
January 1 2005
End Date
August 1 2005
Last Update
September 12 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University College of Medicine
Taipei, Taiwan, 100